A large new study from the University of Bologna has raised questions about a commonly used group of blood pressure medicines ...
Nearly 7 million people in the United States are living with heart failure, and that number is expected to grow in the years ...
Early detection and timely treatment of heart failure in pregnant or postpartum women are crucial to prevent serious ...
Heart failure in the perinatal period remains ambiguous in definition and management despite its recognition as a unique disease state. The true incidence and prevalence of heart failure or left ...
Cardiomyopathy weakens, enlarges, or stiffens the heart muscle. Heart failure is when the heart is unable to pump enough blood around the body, resulting in symptoms. Cardiomyopathy is one of the ...
A new gene therapy can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the amount of blood the heart can pump and dramatically improves ...
People are curious about heart health — and for good reason. Heart disease remains the leading killer of men and women in the U.S. — each year, around 695,000 people die from cardiovascular conditions ...
Heart failure is a leading cause of hospitalization worldwide, and congestion is the predominant cause of heart failure symptoms and hospitalization. The primary therapy used to treat and prevent ...
Heart failure is when the heart does not pump enough blood around the body. Biventricular heart failure is when chambers on both sides of the heart, known as ventricles, are affected. Doctors classify ...
Share on Pinterest People often turn to the internet for answers to common questions regarding their heart health. SDI Productions/Getty Images Cardiovascular disease is the leading cause of death in ...
High blood pressure is a major risk factor for heart disease. Here are some common questions you may have about blood pressure and its relationship to your heart health. You might consider blood ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...